Lv11
70 积分 2026-01-08 加入
New drug therapies for hypertension
6小时前
已完结
Complement in human disease: approved and up-and-coming therapeutics
1个月前
已完结
Oral iptacopan monotherapy in paroxysmal nocturnal haemoglobinuria: final 48-week results from the open-label, randomised, phase 3 APPLY-PNH trial in anti-C5-treated patients and the open-label, single-arm, phase 3 APPOINT-PNH trial in patients previously untreated with complement inhibitors
1个月前
已完结
Serum IgA/C3 ratio: a useful marker of disease activity in patients with IgA nephropathy
4个月前
已完结
The gut microbiota posttranslationally modifies IgA1 in autoimmune glomerulonephritis
4个月前
已完结
From Dose-Finding to Dose-Optimization in Early-Phase oncology clinical trials
4个月前
已完结
TROP-2-targeted antibody-drug conjugate SHR-A1921 for advanced or metastatic solid tumors: A first-in-human phase 1 study
4个月前
已完结
Sacituzumab tirumotecan in advanced non-small-cell lung cancer with or without EGFR mutations: phase 1/2 and phase 2 trials
4个月前
已完结
Once-daily, subcutaneous vosoritide therapy in children with achondroplasia: a randomised, double-blind, phase 3, placebo-controlled, multicentre trial
4个月前
已完结
Automated high-throughput quantification of plasma p-tau217 and APOE-ε4 for Alzheimer’s disease diagnosis and cognitive decline in a memory cohort
4个月前
已关闭
皖公网安备34019202002308
